Review
Bone Marrow Transplantation (2008) 41, 757–764; doi:10.1038/bmt.2008.3; published online 4 February 2008
Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies
P Niscola1, C Romani2, L Scaramucci1, T Dentamaro1, L Cupelli1, A Tendas1, D Piccioni1, M Giovannini1, B Tolu1, C Cartoni3, E Arcuri4, A Perrotti1, R Palumbo5 and P de Fabritiis1
- 1Haematology Division, Sant'Eugenio Hospital, Tor Vergata University, Rome, Italy
- 2Department of Haematology and Transplant Centre, Armando Businco Cancer Centre, Cagliari, Italy
- 3Department of Human Biotechnology and Haematology, La Sapienza University, Rome, Italy
- 4Pain Clinic and Palliative Care Unit, Regina Elena National Cancer Institute, Rome, Italy
- 5Nephrology Unit, Sant'Eugenio Hospital, Rome, Italy
Correspondence: Dr P Niscola, Haematology Division, Sant'Eugenio Hospital, Tor Vergata University, Piazzale dell'Umanesimo 10, Rome 00144, Italy. E-mail: pasquale.niscola@uniroma2.it
Received 1 June 2007; Revised 10 December 2007; Accepted 10 December 2007; Published online 4 February 2008.
Abstract
Severe pain syndromes may be recorded during all phases of haematopoietic stem cell transplantation (HSCT) for haematological malignancies: from stem cell mobilization to the long-term post transplant period. Although the major cause of pain in the setting of HSCT is injury to mucosal tissues induced by the conditioning regimen, pain from several other causes has been reported. In this paper, we review pain and its management in the setting of HSCT.
Keywords:
mucositis, haematopoietic stem cell transplantation, opioids, pain, morphine, patient-controlled analgesia
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Neurotrophic factors as novel therapeutics for neuropathic pain
Nature Reviews Drug Discovery Review (01 Jun 2003)
RESEARCH
Bone Marrow Transplantation Original Article
Ketamine patient-controlled analgesia for dysesthetic central pain
Spinal Cord Correspondence
Bone Marrow Transplantation Original Article
British Journal of Cancer Original Article

